Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 23 announcements

Share price: ₹10.59
Market cap: ₹237.5 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-292.9 Cr
P/E (TTM): -1.0×Sector 47.3×
Promoter holding: 51.84%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 3 Other Announcement 2 Merger & Restructuring 2 Annual General Meeting 2 Financial Results 1 Business Update 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

4 Aug 2026 23:40 IST BSE

Merger & Restructuring

Nectar Lifesciences Merger & Restructuring Worth ₹11.22 Cr

Nectar Lifesciences sold its non-core unit, Narbada Industries, including land leasehold rights and machinery, to Shree Balaji Cold Chain & Storage Services for ₹11.22 Crore.

Value: ₹11.22 Cr

Read the filing ↗

23 Jul 2026 17:09 IST BSE

Merger & Restructuring

Nectar Lifesciences Merger & Restructuring

Nectar Lifesciences extended the expected completion date for the slump sale of its Empty Hard Gelatin Capsule business to Capnest Health Care to December 31, 2026.

Read the filing ↗